Results 311 to 320 of about 2,666,341 (347)
Some of the next articles are maybe not open access.
The Lancet, 2021
Breast cancer is still the most common cancer worldwide. But the way breast cancer is viewed has changed drastically since its molecular hallmarks were extensively characterised, now including immunohistochemical markers (eg, ER, PR, HER2 [ERBB2], and proliferation marker protein Ki-67 [MKI67]), genomic markers (eg, BRCA1, BRCA2, and PIK3CA), and ...
Loibl, Sibylle +4 more
openaire +3 more sources
Breast cancer is still the most common cancer worldwide. But the way breast cancer is viewed has changed drastically since its molecular hallmarks were extensively characterised, now including immunohistochemical markers (eg, ER, PR, HER2 [ERBB2], and proliferation marker protein Ki-67 [MKI67]), genomic markers (eg, BRCA1, BRCA2, and PIK3CA), and ...
Loibl, Sibylle +4 more
openaire +3 more sources
The Lancet, 2005
Extract: Breast cancer is a major public-health issue on a global scale. According to estimates in 2002, there were 1,151,298 new cases of breast cancer diagnosed world-wide. Between 1951 and 1990, mortality from breast cancer rates rose but have since fallen in most European countries, noticeably in the UK. In Japan the mortality rates have been lower
U. Veronesi +4 more
openaire +5 more sources
Extract: Breast cancer is a major public-health issue on a global scale. According to estimates in 2002, there were 1,151,298 new cases of breast cancer diagnosed world-wide. Between 1951 and 1990, mortality from breast cancer rates rose but have since fallen in most European countries, noticeably in the UK. In Japan the mortality rates have been lower
U. Veronesi +4 more
openaire +5 more sources
New England Journal of Medicine, 1980
TWELVE years ago in the Journal, Dr. F. D. Moore and his colleagues evaluated the various forms of therapy then current for the treatment of both primary and metastatic breast carcinoma.1 In 1967 most patients with breast cancer were treated initially with mastectomy, and at the time of relapse one of various endocrine treatments was employed.
Marc E. Lippman, Joseph C. Allegra
openaire +3 more sources
TWELVE years ago in the Journal, Dr. F. D. Moore and his colleagues evaluated the various forms of therapy then current for the treatment of both primary and metastatic breast carcinoma.1 In 1967 most patients with breast cancer were treated initially with mastectomy, and at the time of relapse one of various endocrine treatments was employed.
Marc E. Lippman, Joseph C. Allegra
openaire +3 more sources
The American Journal of Surgery, 1973
Abstract A consecutive series of 457 patients with breast cancer is reviewed. Tumor size, duration, and extent of nodal involvement are very important factors in prognosis. We continue to believe that so-called radical mastectomy is the surgical procedure of choice in suitable patients because of the finding of 30 per cent positive nodes in ...
John D. Coe, Charles W. McLaughlin
openaire +2 more sources
Abstract A consecutive series of 457 patients with breast cancer is reviewed. Tumor size, duration, and extent of nodal involvement are very important factors in prognosis. We continue to believe that so-called radical mastectomy is the surgical procedure of choice in suitable patients because of the finding of 30 per cent positive nodes in ...
John D. Coe, Charles W. McLaughlin
openaire +2 more sources
JAMA, 1960
To the Editor:— I am writing in reference to an unsigned review of the monograph entitled "Cancer of the Breast" (edited by W. H. Parsons, Springfield, Ill., Charles C Thomas, Publisher, 1959) inThe Journal, April 2, page 1573. By a recent and highly desirable change in the policy ofThe Journal, book reviewers are now permitted to sign their reviews ...
openaire +2 more sources
To the Editor:— I am writing in reference to an unsigned review of the monograph entitled "Cancer of the Breast" (edited by W. H. Parsons, Springfield, Ill., Charles C Thomas, Publisher, 1959) inThe Journal, April 2, page 1573. By a recent and highly desirable change in the policy ofThe Journal, book reviewers are now permitted to sign their reviews ...
openaire +2 more sources
THE CURABILITY OF BREAST CANCER
The Lancet, 1975AbstractA long‐term follow‐up study was performed of 704 women who were treated for breast cancer during 1947–50 at Addenbrooke's Hospital, Cambridge, England. After 21 years the observed survival curve for the treated patients and the expected survival curve for the normal population became parallel, suggesting a “cure rate” of about 18% for all cases
J. L. Haybittle, Diana Brinkley
openaire +6 more sources
The American Journal of Surgery, 1952
C ANCER of the breast is not new. In the first century A.D. Leonides112 operated upon the breast for cancer, using a red hot iron to sear the remaining surfaces. AntyIIus’ also operated upon the breast in the third century. In 1804 Benjamin Bell’ insisted that local operations were of no avaiI and urged that wider operations were necessary and ...
openaire +3 more sources
C ANCER of the breast is not new. In the first century A.D. Leonides112 operated upon the breast for cancer, using a red hot iron to sear the remaining surfaces. AntyIIus’ also operated upon the breast in the third century. In 1804 Benjamin Bell’ insisted that local operations were of no avaiI and urged that wider operations were necessary and ...
openaire +3 more sources